Bionano Announces Preliminary 3Q 2024 Revenues and Cash

SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended September 30, 2024. The Company now expects revenue for the third quarter of 2024 to be between $6.5 and$6.8 million, down from prior guidance of between $7.9 and$8.9 million. Cash, cash equivalents, available-for-sale securities, and restricted cash were approximately $23.3 million as ofSeptember 30, 2024, of which$11.4 millionwas subject to certain restrict ...